News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
279 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26680)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (335)
2 (389)
3 (283)
4 (319)
5 (131)
6 (6)
7 (4)
8 (279)
9 (329)
10 (321)
11 (307)
12 (125)
13 (3)
14 (8)
15 (254)
16 (287)
17 (204)
18 (246)
19 (94)
20 (14)
21 (3)
22 (244)
23 (272)
24 (225)
25 (255)
26 (87)
27 (4)
28 (5)
29 (233)
30 (284)
31 (251)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
FDA
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021
Veristat, a scientific-minded, global clinical research organization (CRO), today congratulated Origin Biosciences for their FDA approval of Nulibry (fosdenopterin) for injection as the first therapy to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.
March 8, 2021
·
2 min read
Biotech Bay
Fierce Medtech Names Avail Medsystems as One of its “Fierce 15” Companies of 2020
Avail Medsystems, a medical technology company that is pioneering telemedicine for the procedure room, announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry.
March 8, 2021
·
3 min read
Drug Development
Oncoinvent Announces Progression of Radspherin® to Third Dose Level Cohort in Ongoing RAD-18-001 Phase 1 Trial in Platinum Sensitive Recurrent Ovarian Cancer Patients with Peritoneal Carcinomatosis
Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, today announced the advancement of its ongoing Phase 1 clinical study of Radspherin® in ovarian cancer patients suffering from peritoneal carcinomatosis to the third level dose cohort following approval from the trial Safety Monitoring Committee
March 8, 2021
·
3 min read
Pharm Country
Fierce Medtech names Hyperfine as one of its “Fierce 15” companies of 2020
Hyperfine Research has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most innovative and creative private companies in the industry with its category-defining Swoop™ Portable MR Imaging System.
March 8, 2021
·
4 min read
Pharm Country
Applied DNA to Participate in Upcoming Conferences
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor conferences.
March 8, 2021
·
1 min read
NervGen Pharma Receives Orphan Designation from the European Medicines Agency for NVG-291 for the Treatment of Spinal Cord Injury
This new EMA designation provides NervGen with multiple incentives, including improved access to scientific advice, fee reductions, and 10 years of protection from market competition in Europe from similar medicines with similar indications following the date that the drug candidate receives marketing authorization (called market exclusivity).
March 8, 2021
·
7 min read
Business
Leading Femtech Brand INNOVO Attracts Two New Investors
INNOVO adds significant incremental investment for pioneering home-based treatment for stress urinary incontinence, a condition that impacts 1 in 3 women worldwide Netherland’s Borski Fund backs female-led, femtech focused companies
March 8, 2021
·
6 min read
Deals
Levine Leichtman Capital Partners Portfolio Company Therapeutic Research Center Acquires NetCE
Therapeutic Research Center, LLC, a portfolio company of Levine Leichtman Capital Partners, announced that it has acquired CE Resources, Inc., d/b/a NetCE.
March 8, 2021
·
3 min read
Business
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the promotion of Dr. Caroline Kurtz to Chief Development Officer. As Chief Development Officer,
March 8, 2021
·
5 min read
Policy
Court Orders FSD Pharma to Move Shareholder Meeting Date to May 14, 2021, Imposes Requirement of an Independent Meeting Chair and Prevents Dr. Raza Bokhari and Other Directors from Voting Recently Issued Shares
The group of concerned shareholders Concerned Shareholders of FSD Pharma Inc. which includes two founding directors, Anthony Durkacz and Zeeshan Saeed , are pleased to announce that they were successful in their request that the Ontario Superior Court of Justice order the Company to accelerate the date of its previously called annual shareholders meeting.
March 8, 2021
·
6 min read
Previous
7 of 28
Next